Applied Therapeutics, Inc. — Director's Dealing 2019

May 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2019-05-16

Reporting Person: MARCUS JOEL S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-16	Common Stock	C	110497	—	Acquired	119668	Direct
2019-05-16	Common Stock	C	135192	—	Acquired	254860	Direct
2019-05-16	Common Stock	P	150000	$10.00	Acquired	404860	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-16	Series A Preferred Stock	$	C	110497	Disposed		Common Stock (110497)	Direct
2019-05-16	Series B Preferred Stock	$	C	135192	Disposed		Common Stock (135192)	Direct

Footnotes

F1: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019.